ProCE Banner Activity

Doing More With Less: Moving Toward Intermittent ART Dosing Strategies for Extended Virologic Suppression in France

Clinical Thought
The future must provide a way to decrease the therapeutic burden for people with HIV without compromising ART efficacy&mdash improving the overall experience for the patient by doing more with less.

Released: January 04, 2023

Expiration: January 03, 2024

Share

Provided by

ProCE Banner

Supporters

Gilead Sciences, Inc.

ViiV Healthcare

Faculty Disclosure

Primary Author

Christine Katlama, MD

Professor
Sorbonne University APHP Paris
Head, HIV/Hepatitis Clinical and Research Unit
Department of Infectious Diseases
Paris, France

Christine Katlama, MD: consultant/advisor/speaker: Gilead Sciences, Merck Sharp & Dohme, ViiV Healthcare; researcher: Gilead Sciences, Merck Sharp & Dohme, ViiV Healthcare.